Home > Insider Trading > Filing (0001140361-11-001839)

Filing Details

Accession Number:: 0001140361-11-001839
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-01-07 12:52:44
Reporting Period:: 2011-01-05

Filing Date:: 2011-01-07
Accepted Time:: 2011-01-07 12:52:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
707511	Regenerx Biopharmaceuticals Inc	RGRX.OB	Pharmaceutical Preparations (2834)	521253406

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1164803	Claudio Cavazza	Pontina Km. 30,400 Pomezia (Rome) L6 00040		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-05	1,296,296	$0.27	6,348,878	No	4	P	Indirect	Indirect
Common Stock	Acquisiton	2011-01-05	925,926	$0.27	12,937,111	No	4	P	Indirect	Indirect

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Indirect
No	4	P	Indirect	Indirect

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	518,518	$0.38
Common Stock	Common Stock Warrant (right to buy)	Disposition	2011-01-05	1	$0.00	22,601	$4.06
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	22,601	$0.38
Common Stock	Common Stock Warrant (right to buy)	Disposition	2011-01-05	1	$0.00	333,333	$2.75
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	333,333	$0.38
Common Stock	Common Stock Warrant (right to buy)	Disposition	2011-01-05	1	$0.00	500,000	$1.60
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	500,000	$0.38
Common Stock	Common Stock Warrant (right to buy)	Disposition	2011-01-05	1	$0.00	372,552	$1.74
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	372,552	$0.38
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	370,370	$0.38
Common Stock	Common Stock Warrant (right to buy)	Disposition	2011-01-05	1	$0.00	256,148	$4.06
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	256,148	$0.38
Common Stock	Common Stock Warrant (right to buy)	Disposition	2011-01-05	1	$0.00	333,333	$2.75
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2011-01-05	1	$0.00	333,333	$0.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1	2011-07-07	2016-01-07	No	4	J	Indirect
0		2011-03-16	No	4	J	Indirect
1		2011-12-31	No	4	J	Indirect
0		2011-12-21	No	4	J	Indirect
2		2011-12-31	No	4	J	Indirect
0		2010-12-31	No	4	J	Indirect
3		2011-12-31	No	4	J	Indirect
0		2011-12-31	No	4	J	Indirect
4		2011-12-31	No	4	J	Indirect
1	2011-07-07	2016-01-07	No	4	J	Indirect
0		2011-03-16	No	4	J	Indirect
1		2011-12-31	No	4	J	Indirect
0		2011-12-21	No	4	J	Indirect
2		2011-12-31	No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	984,615	Indirect	Indirect

Footnotes

1,034,482 of these shares were acquired by Inverlochy Consultadoria e Servicos Lda ("Inverlochy") on December 10, 2008 pursuant to a purchase agreement with the Issuer that provides that the Issuer, rather than the holder, has all voting rights in respect of such shares through December 31, 2011, and that the holder may not transfer such shares through December 31, 2011 except for transfers to Affiliates (as defined therein). On June 29, 2010, Inverlochy merged with and into Taufin International S.A. ("Taufin"), its direct parent, which is a direct wholly-owned subsidiary of Taufin S.p.A. Taufin S.p.A. is owned by Claudio Cavazza.
Securities directly owned by Taufin.
Securities directly owned by Defiante Farmaceutica S.A. ("Defiante"). Defiante is 58% directly owned by Sigma Tau Finanziaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidiary, Sigma Tau International S.A. Claudio Cavazza directly and indirectly owns 57% of Sigma Tau.
Securities directly owned by Sigma Tau.
The Warrant was issued by the Issuer to the holder in consideration of the holders's purchase of Common Stock.
The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on September 16, 2006.
The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 21, 2006.
The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on February 29, 2008.
The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 10, 2008.
The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on September 16, 2006.
The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 21, 2006.